TrialBMJ open2015

Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease.

Stephanie Stephens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.